New data shows that targeted investment is reducing disruption in healthcare supply chains
DP World says targeted logistics investment is reducing disruption costs for healthcare companies
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Global healthcare deal value increased in October 2025: GlobalData
GlobalData reports higher M&A and venture investment activity in the healthcare sector in October 2025.
Guaranteeing continuity of medicine supply through AI innovation
Whenever we speak of pharmaceutical innovation, we often focus on novel molecules or path-breaking therapies. The COVID 19…
Direct-to-Retail will increasingly complement traditional pharma distribution
Aqualab has crossed Rs 100 crore in just three years, what have been the key drivers behind this growth, and how does the brand…
India’s biopharma industry charts the road from biosimilars to innovation
Express Pharma hosted the maiden Biopharma Leadership Conclave 2025 and brought together industry leaders to discuss how India can…
AI and real-world evidence: The next frontier in clinical research
In the rapidly evolving world of clinical research, few developments hold as much promise—or provoke as much debate—as the…
Farmson unveils ₹300 Crore Acetic Anhydride unit in Vadodara
Farmson Basic Drugs unveiled its state-of-the-art Unit-VI manufacturing facility in Nandesari, Vadodara, Gujarat. This modern …
How HVAC is evolving from utility to critical quality enabler
Once viewed as a background utility, HVAC systems have become crucial to pharmaceutical manufacturing — enabling contamination…
Venus Remedies’ Methotrexate, Cefuroxime, and Irinotecan enters Vietnam
Venus Remedies has secured new marketing authorizations for Methotrexate, Cefuroxime, and Irinotecan in Vietnam. These regulatory…
Emcutix Biopharma unveils new AquaOat range in liposomal delivery of nano ceramide
Emcutix Biopharmaceuticals, a wholly-owned subsidiary of Emcure PharmaceuticalsL has announced the launch of the new AquaOat…